Richard M. Fox

2.7k total citations
86 papers, 2.1k citations indexed

About

Richard M. Fox is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Richard M. Fox has authored 86 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Oncology and 14 papers in Genetics. Recurrent topics in Richard M. Fox's work include Biochemical and Molecular Research (13 papers), Cytomegalovirus and herpesvirus research (10 papers) and HIV/AIDS drug development and treatment (8 papers). Richard M. Fox is often cited by papers focused on Biochemical and Molecular Research (13 papers), Cytomegalovirus and herpesvirus research (10 papers) and HIV/AIDS drug development and treatment (8 papers). Richard M. Fox collaborates with scholars based in Australia, United States and Belgium. Richard M. Fox's co-authors include Richard Kefford, Martin H.N. Tattersall, Carolyn E. Mountford, Jonathan Cebon, C. Glenn Begley, William J. O’Sullivan, Michael D. Green, E. Tripp, Russell L. Basser and Robert L. Woods and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Richard M. Fox

83 papers receiving 1.9k citations

Peers

Richard M. Fox

ONCOL

HEMAT

EPIDE

GENET

J Jacobs United States

J F Smyth United Kingdom

P. Meera Khan Netherlands

Duane R. Schultz United States

Gary Gilliland United States

Yutaka Tanaka Japan

John Hozier United States

Michael Courtney France

Aldur W. Eriksson Finland

Barbara Beatty United States

J Jacobs United States

Richard M. Fox

1.2k ×1.5

711 ×1.6

ONCOL

327 ×0.8

HEMAT

398 ×1.6

EPIDE

510 ×2.5

GENET

Citations per year, relative to Richard M. Fox Richard M. Fox (= 1×) peers J Jacobs

Countries citing papers authored by Richard M. Fox

Since Specialization

Citations

This map shows the geographic impact of Richard M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Fox more than expected).

Fields of papers citing papers by Richard M. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Fox. The network helps show where Richard M. Fox may publish in the future.

Co-authorship network of co-authors of Richard M. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Fox. A scholar is included among the top collaborators of Richard M. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Fox. Richard M. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gibbs, Peter, Tracey J. Brown, Raymond Ng, et al.. (2008). A Pilot Human Evaluation of a Formulation of Irinotecan and Hyaluronic Acid in 5-Fluorouracil-Refractory Metastatic Colorectal Cancer Patients. Chemotherapy. 55(1). 49–59. 28 indexed citations

Ellis, David W., Michael Eaton, Richard M. Fox, et al.. (2005). Diagnostic pathology of lymphoproliferative disorders. Pathology. 37(6). 434–456. 10 indexed citations

Rosenthal, Mark, Peter Gibbs, Tracey J. Brown, et al.. (2005). Phase I and Pharmacokinetic Evaluation of Intravenous Hyaluronic Acid in Combination with Doxorubicin or 5-Fluorouracil. Chemotherapy. 51(2-3). 132–141. 21 indexed citations

Seymour, John F., Andrew Grigg, Jeff Szer, & Richard M. Fox. (2002). Cisplatin, fludarabine, and cytarabine. Cancer. 94(3). 585–593. 26 indexed citations

Appu, Sree, Helen E. O’Connell, Laurence K. Cleeve, & Richard M. Fox. (2001). Extragonadal choriocarcinoma involving the kidney. ANZ Journal of Surgery. 71(5). 325–327. 2 indexed citations

Davis, Ian D., Jonathan Cebon, Michael D. Green, et al.. (2000). A Phase I and Pharmacokinetic Study of Subcutaneously-Administered Recombinant Human Interleukin-4 (rhuIL-4) in Patients with Advanced Cancer. Growth Factors. 17(4). 287–300. 3 indexed citations

Parker, Nigel J., C. Glenn Begley, Peter J. Smith, & Richard M. Fox. (1996). Molecular Cloning of a Novel Human Gene (D11S4896E) at Chromosomal Region 11p15.5. Genomics. 37(2). 253–256. 67 indexed citations

Parker, Nigel J., C. Glenn Begley, & Richard M. Fox. (1995). Human Gene for the Large Subunit of Ribonucleotide Reductase (RRM1): Functional Analysis of the Promoter. Genomics. 27(2). 280–285. 13 indexed citations

Parker, Nigel J., C. Glenn Begley, & Richard M. Fox. (1994). Human R1 Subunit of Ribonucleotide Reductase (RRM1): 5′ Flanking Region of the Gene. Genomics. 19(1). 91–96. 9 indexed citations

10.

Farag, Sherif S., Michael D. Green, George Morstyn, William Sheridan, & Richard M. Fox. (1992). Delay by Internists in Obtaining Diagnostic Biopsies in Patients with Suspected Cancer. Annals of Internal Medicine. 116(6). 473–478. 10 indexed citations

11.

Basser, Russell L., Michael D. Green, William Sheridan, & Richard M. Fox. (1992). Pilot study of escalating doses of carboplatin and cyclophosphamide in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 30(2). 161–163. 1 indexed citations

12.

Marks, David I. & Richard M. Fox. (1991). DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action. Biochemical Pharmacology. 42(10). 1859–1867. 43 indexed citations

13.

Parker, Nigel J., C. Glenn Begley, & Richard M. Fox. (1991). Human M1 subunit of ribonucleotide reductase: cDNA sequence and expression in stimulated lymphocytes. Nucleic Acids Research. 19(13). 3741–3741. 12 indexed citations

14.

Marks, David I., et al.. (1991). Prevention Of Cyclophosphamide-Induced And Spontaneous Diabetes In Nod Mice By Syngeneic Splenocytes Treated With Cytotoxic Drugs. Autoimmunity. 11(2). 73–79. 4 indexed citations

15.

Fox, Richard M., et al.. (1988). New Directions in Ethics. Tijdschrift voor Philosophie. 50(4). 3 indexed citations

16.

May, George L., Lesley C. Wright, Marlen Dyne, et al.. (1988). Plasma membrane lipid composition of vinblastine sensitive and resistant human leukaemic lymphoblasts. International Journal of Cancer. 42(5). 728–733. 65 indexed citations

17.

Fox, Richard M., Richard Kefford, E. Tripp, & Ian W. Taylor. (1981). G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.. PubMed. 41(12 Pt 1). 5141–50. 48 indexed citations

18.

Raghavan, Derek, Tatiana Jelihovsky, & Richard M. Fox. (1980). Father-son testicular malignancy does genetic anticipation occur?. Cancer. 45(5). 1005–1009. 28 indexed citations

19.

Fox, Richard M.. (1979). The Honorific Meaning of 'Sport'. 9. 84–94. 3 indexed citations

20.

Fox, Richard M.. (1964). HISTORY AND PHILOSOPHY OF SCIENCE. Proceedings of the American Catholic Philosophical Association. 38. 209–216. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact